National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 1379 cases where Vaccine is HPV2 and Serious

Table

   
AgeCountPercent
< 3 Years30.22%
6-9 Years10.07%
9-12 Years765.51%
12-17 Years69550.4%
17-44 Years23817.26%
44-65 Years80.58%
Unknown35825.96%
TOTAL1379100%

Case Details

This is page 1 out of 138

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 391384 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Ohio  
Vaccinated:2010-03-25
Onset:2010-05-01
   Days after vaccination:37
Submitted: 2010-06-24
   Days after onset:54
Entered: 2010-06-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS A4PVA085BC / 2 LA / UN

Administered by: Private       Purchased by: Private
Symptoms: Electromyogram abnormal, Grip strength decreased, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Allergies:
Diagnostic Lab Data: EMG positive, spinal tap positive, other causes ruled out during hospitalization
CDC Split Type:

Write-up: Hand numbness then loss of grip strength then progressed to leg weakness gradual onset. EMG positive for Guillain Barre Syndrome and Hospitalized for IVIG on 06/16/2010. Resolution of symptoms at office visit on 06/23/2010.


VAERS ID: 435174 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2011-08-01
Onset:0000-00-00
Submitted: 2011-09-22
Entered: 2011-09-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113AA / 1 RA / IJ

Administered by: Private       Purchased by: Private
Symptoms: Intra-uterine death, Maternal exposure during pregnancy, Uterine dilation and curettage
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient was 2-3 weeks pregnant at time of vaccination. Possible birth defect caused fetal demise at 6 weeks 6 days of gestation. DNC was required.


VAERS ID: 453908 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Male  
Location: Washington  
Vaccinated:2011-08-30
Onset:2012-04-12
   Days after vaccination:226
Submitted: 2012-04-16
   Days after onset:4
Entered: 2012-04-17
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113AA / 1 RA / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U3846AA / 1 LA / IM

Administered by: Private       Purchased by: Unknown
Symptoms: Asthma, Blood glucose increased, Cachexia, Condition aggravated, Cough, Dehydration, Diarrhoea, Glucose urine present, Polydipsia, Polyuria, Type 1 diabetes mellitus, Urine ketone body present, Weight decreased, Wrong drug administered
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Noninfectious diarrhoea (narrow), Tubulointerstitial diseases (broad), Medication errors (narrow), Dehydration (narrow), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Mild asthma
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Per mother since vaccination, pt started to lose weight & was diagnosed with Type I DM 4/12/12, concerned because pt was given CERVARIX in error.


VAERS ID: 463963 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2012-05-14
Onset:2012-05-14
   Days after vaccination:0
Submitted: 2012-09-04
   Days after onset:113
Entered: 2012-09-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA113BB / 1 UN / UN
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. 1295AA / UNK UN / UN

Administered by: Private       Purchased by: Private
Symptoms: Fatigue, Influenza like illness, Nausea, Oedema peripheral, Pain
SMQs:, Cardiac failure (broad), Acute pancreatitis (broad), Angioedema (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: The subject had no concomitant medications and no known allergies.
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: A0991830A

Write-up: This case was reported by a physician, via a sales representative, and described the occurrence of body pain in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline), VARIVAX (non-gsk). On 14 May 2012 at 16:30 the subject received 1st dose of CERVARIX (.5 ml, unknown route) and on 14 May 2012 the subject received 2nd dose of VARIVAX (Non-GSK) (details unknown). On 14 May 2012, 1 hour after vaccination with CERVARIX and VARIVAX (Non-GSK), the subject experienced "overall" body pain, swelling arm, flu like symptoms, fatigue and nausea. The physician considered the events were disabling. The events lasted for 3 days. On 17 May 2012, the events were resolved. The subject consulted her healthcare provider. The vaccination course with CERVARIX was discontinued.


VAERS ID: 472685 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Georgia  
Vaccinated:2010-09-02
Onset:2012-09-22
   Days after vaccination:751
Submitted: 2012-10-27
   Days after onset:35
Entered: 2012-11-02
   Days after submission:6
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS 0216V / 1 LA / IM

Administered by: Private       Purchased by: Other
Symptoms: Abasia, Abdominal pain upper, Crying, Haematemesis, Headache, Loss of consciousness, Muscle spasms, Panic attack, Pelvic pain, Urticaria
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dystonia (broad), Gastrointestinal haemorrhage (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations: Adverse event.~HPV (no brand name)~1~13.00~Patient
Other Medications: None
Current Illness: No
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Dr. gave 1st HPV 9-2-10. Within a few days, pt. passed out, in 2 weeks passed out again. Spit up blood, bad headaches, stomach ache, hives. Dr. gave her HPV shot; recommended booster in 1 month. She passed out a week later, had panic attack, bad headaches, stomach and pelvic pain, legs cramping up at night. Waking crying, couldn''t walk at first.


VAERS ID: 491885 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: Indiana  
Vaccinated:2013-05-10
Onset:2013-05-10
   Days after vaccination:0
Submitted: 2013-05-17
   Days after onset:7
Entered: 2013-05-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA174BJ / 2 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Blood gases, Blood glucose, Cardiac monitoring, Computerised tomogram head, Dizziness, Drug screen, Electrocardiogram, Full blood count, Grip strength decreased, Headache, Incoherent, Metabolic function test, Somnolence
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Drug abuse and dependence (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Metformin 1 tablet qd
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CBC; CMV; CT scan head; Hospital stay x24h
CDC Split Type:

Write-up: About 5:30 pm patient c/o headache. C/O mom found patient in tub asleep about 6 pm. Patient got out of tub was in moms room bent over to pick up cup. Patient could not grab a hold of cup. C/O dizziness, talking to mom incoherently. Took to ER local. Patient was real drowsy want to sleep. ER did - EKG, blood test, B/S, Blood gases CT scan drug testing U/A. ER couldn''t find out the problem. Transfer by helicopter to hospital. Heart monitored overnight. Patient was fine the next morning.


VAERS ID: 534568 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2014-03-20
Onset:2014-04-28
   Days after vaccination:39
Submitted: 2014-06-21
   Days after onset:54
Entered: 2014-06-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS PH43F / 3 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Blindness unilateral, Eye pain, Headache, Lumbar puncture, Nuclear magnetic resonance imaging, Optic neuritis
SMQs:, Glaucoma (broad), Optic nerve disorders (narrow), Demyelination (narrow), Retinal disorders (broad), Ocular infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: MRI, Lumbar Puncture
CDC Split Type:

Write-up: Patient began severe headache with rght eye pain which lasted for three weeks and was misdiagnosed as a sinus infection and migraine. Patient lost complete vision in right eye and was diagnosed with optic neuritis on 5/21/2014 and hospitalized.


VAERS ID: 546972 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Unknown  
Vaccinated:2011-04-25
Onset:2011-04-25
   Days after vaccination:0
Submitted: 2014-10-06
   Days after onset:1260
Entered: 2014-10-07
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Blood test normal, Eye irritation, Headache, Mydriasis, Nausea, Visual impairment, Vomiting
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Optic nerve disorders (broad), Lens disorders (broad), Corneal disorders (broad), Retinal disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Seasonal allergy; Asthma
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: A201105703

Write-up: This case was reported by a physician and described the occurrence of vomiting in a 15-year-old female subject who was vaccinated with CERVARIX. On 25 April 2011 the subject received unspecified dose of CERVARIX (.5 ml, intramuscular). On 25 April 2011, at an unspecified time after vaccination with CERVARIX, the subject experienced vomiting, headache and mydriasis. At the time of reporting the events were unresolved. The physician considered the events were related to vaccination with CERVARIX. Follow-up information received on 17 May 2011: Concurrent medical conditions included asthma and seasonal allergy. Lot number was provided. The vaccine was administered in right deltoid. On 25 April 2011, less than one day after vaccination with CERVARIX, the subject experienced vomiting, and mydriasis. On 26 April 2011, one day after vaccination with CERVARIX, the subject experienced headache, queasy, vision disturbance and irritation when opening the eyes. A blood test was performed and showed no abnormality. On 28 April 2011, the events were improved. On 6 May 2011, the headache and queasy recurred. Follow-up information received on 18 May 2011: Previous vaccination included 1st dose of CERVARIX (GlaxoSmithKline, intramuscular, unknown injection site) given on 25 March 2011. This case has been linked to case B0718792A because it was a duplicate. All future correspondence will be submitted to B0716098A. Follow-up information received on 26 May 2011: The subject was treated with unknown (Infusion) and unknown (Unknown medication).


VAERS ID: 596167 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Unknown  
Vaccinated:2012-12-26
Onset:0000-00-00
Submitted: 2015-09-18
Entered: 2015-09-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA164AA / 3 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Biopsy skin abnormal, Blood catecholamines increased, Complex regional pain syndrome, Orthostatic intolerance, Pain, Pain in extremity, Palpitations, Plethysmography, Postural orthostatic tachycardia syndrome, Schellong test, Temperature difference of extremities, Tremor
SMQs:, Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Parkinson-like events (broad), Noninfectious encephalopathy/delirium (broad), Hypertension (broad), Cardiomyopathy (broad), Skin tumours of unspecified malignancy (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions: 05/14/2012, CERVARIX, dose 1 - AHPVA162AA; 06/16/2012, CERVARIX, dose 2 - AHPVA162AA
Allergies:
Diagnostic Lab Data: The subject underwent the following tests: Schellong test (maximum change decreased systolic blood pressure: 1 mmHg; increased heart rate/minute: 48), measurement of catecholamine plasma levels (Noradrenaline at supine position: 0.22 ng/mL, Increasing rate of noradrenaline: 100%), evaluation of skin temperature (2nd finger: 33.2, 1st toe: 24.1, room temperature 23-25 deg C) and digital plethysmogram (2nd finger: decreased height of waves, 1st toe: decreased height of waves). In addition to this, a punch biopsy of the skin of the first toe was performed and no pathological findings were identified. Upon light microscopic examination, three small nerve fascicles were identified in one skin sample and some of these nerve fascicles were near apocrine glands (where sudomotor autonomic unmyelinated nerves were thought to be present, according to the authors). Upon electron microscopic examinations, one fascicle was found to consist of a small number of myelinated nerve fibers (most of them <5 um in diameter) and a large number of unmyelinated nerve fibers.
CDC Split Type: US2014GSK041878

Write-up: This case was reported by a physician via regulatory authority and described the occurrence of postural orthostatic tachycardia syndrome on a 15-year-old female patient who received CERVARIX (batch number AHPVA164AA, expiry date unknown). Previously administered products included CERVARIX (dose 1 - AHPVA162AA) and CERVARIX (dose 2 - AHPVA162AA). On 26th December 2012, the patient received the 3rd dose of CERVARIX. In December 2012, less than a month after receiving CERVARIX, the patient experienced postural orthostatic tachycardia syndrome (serious criteria hospitalization and disability), generalized aching and palpitation. On an unknown date, the outcome of the postural orthostatic tachycardia syndrome, generalized aching and palpitation were not recovered/not resolved. It was unknown if the reporter considered the postural orthostatic tachycardia syndrome, generalized aching and palpitation to be related to CERVARIX. Additional information: The case was reported by a physician (Neurology and rheumatology department) via the regulatory authority but it was confirmed the patient was vaccinated with all the 3 doses. The causal relationship to CERVARIX was unassessable. On 13 April 2015, after GSK internal review and requested clarification, it was confirmed the patient was not hospitalized and therefore hospitalization was removed as seriousness criteria. On 7 September 2015, this case has been identified as a duplicate of case JP2014JPN009776. Case JPN2014JPN009776 will be deleted and all future correspondence will be submitted to US2014GSK041878 which stands as the case of record. This case also reported in a literature article, this case corresponds to patient in the article: This case was reported in a literature article and it described a case of concurrent orthostatic dysregulation and complex regional pain syndrome I (according to the criteria of the Association) in a 15-year-old female subject who had received CERVARIX (GlaxoSmithKline). No information on the subject''s medical history, concurrent medical conditions or concomitant medication was provided. On an unspecified date, the subject received at least dose of CERVARIX (dosage, administration route and site unknown; batch number not provided). On an unknown date between 21 June 2013 and 31 March 2014, an unknown period after the administration of the vaccine, the subject presented with limb pain, limb tremors and decrease temperature in toe. The authors reported that some of the subjects had been severely disabled by their conditions. The subject underwent the following tests: Schellong test (maximum change decreased systolic blood pressure: 1 mmHg; increased heart rate/minute: 48), measurement of catecholamine plasma levels (Noradrenaline at supine position: 0.22 ng/mL, Increasing rate of noradrenaline: 100%), evaluation of skin temperature (2nd finger: 33.2, 1st toe: 24.1, room temperature 23-25 degC) and digital plethysmogram (2nd finger: decreased height of waves, 1st toe: decreased height of waves). In addition to this, a punch biopsy of the skin of the first toe was performed and no pathological findings were identified. Upon light microscopic examination, three small nerve fascicles were identified in one skin sample and some of these nerve fascicles were near apocrine glands (where sudomotor autonomic unmyelinated nerves were thought to be present, according to the authors). Upon electron microscopic examinations, one fascicle was found to consist of a small number of myelinated nerve fibers (most of them less than 5 um in diameter) and a large number of unmyelinated nerve fibers. Treatment was unknown. At the time of reporting the outcome of the events was unspecified. The authors mentioned that a causal relationship between the human papillomavirus vaccine and the events described in the article could be possible. They argued that this possibility was reinforced by the unusual concurrence of complex regional pain syndrome and orthostatic dysregulation in some of the subjects, as well as the lack of preceding viral infections in the 4 subjects diagnosed with postural orthostatic tachycardia syndrome. The authors concluded that "The symptoms observed in this study can be explained by abnormal peripheral sympathetic responses. The most common previous diagnosis in the studied girls was psychosomatic disease. The social problems of the study participants remained unresolved in that the severely disabled girls stopped going to school". This case is 1 of the 22 valid cases reported in the same literature article.


VAERS ID: 698773 (history)  
Form: Version 1.0  
Age: 55.0  
Sex: Female  
Location: Missouri  
Vaccinated:2017-05-08
Onset:2017-05-14
   Days after vaccination:6
Submitted: 2017-06-08
   Days after onset:25
Entered: 2017-06-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / -
MEN: MENINGOCOCCAL (MENOMUNE) / SANOFI PASTEUR - / UNK UN / -

Administered by: Public       Purchased by: Public
Symptoms: Abscess, Cerebral disorder, Cough, Deafness unilateral, Ear pain, Headache, Hypotension, Mastoiditis, Oral fungal infection, Oropharyngeal pain, Pain, Pneumococcal infection, Productive cough, Pyrexia, Sepsis, Sinus pain, Sneezing, Thrombosis
SMQs:, Anaphylactic reaction (narrow), Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Oropharyngeal infections (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Thrombophlebitis (broad), Hearing impairment (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Albuterol inhaler, dulera inhaler, cetrizine. My stepson received the meningitis vaccine, I got sick 6 days later, hospitalized on the 24th of May with bacterial meningitis.
Current Illness: No
Preexisting Conditions: Allergies
Allergies:
Diagnostic Lab Data: Blood clots in brain, Acute mastoiditis of left side, Hearing loss in left ear, Low blood pressure, Acute brain disorder, Abscess in head, pneumococcal infection of spinal fluid, Disorder of Intracranial venous sinus, severe headache, Infection in blood stream, Low blood pressure, oral yeast infection.
CDC Split Type:

Write-up: Sneezing, sore throat, headache, body aches, phlegmy cough, earache, sinus pain, fever.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX[]=HPV2&SERIOUS=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166